Vidac Pharma to list on Hamburg Stock Exchange

The Israeli clinical stage oncology drug developer has a share subscription facility of up to €20 million from Luxembourg-based GEM.

Related Keywords

Germany ,Luxembourg ,Hamburg ,Israel ,Israeli ,Loren Becker ,Shmuel Kabili ,Miguel Ahuvi ,Europe Vidac ,Vidac Pharma ,Max Herzberg ,Lisrael Biotech Fund ,Global Yield ,Koronis Foundation ,Hamburg Stock Exchange ,Nasdaq ,Hamburg Stock ,Vidac Shares ,Sepal Pharma ,Becker Photo ,